Artificial Intelligence (AI) can create a meaningful impact on customer engagement in the pharmaceutical and life sciences industries, with virtual agents emerging as a powerful tool for patient interaction and data collection. These agents offer personalized experiences and real-time support throughout the patient journey. Despite their potential, over 72% of pharma marketers currently lack a dedicated budget for this solution, indicating a significant opportunity for growth and innovation in this space.
At a recent MM+M roundtable, leaders in the industry gathered to discuss the benefits and challenges of integrating AI virtual agents into pharma marketing strategies. These intelligent systems can enhance the analysis of voice-of-the-customer (VOC) data and website analytics, providing valuable insights into patient needs and preferences.
From gathering real-time data to inform marketing strategies to improving the overall patient experience, AI-powered virtual agents can help personalize customer interactions. Yet, many brands struggle with monitoring these tools, and evolving data and privacy regulations further complicates engagement.
Catch up on the full discussion from the roundtable.